Drug Trial Radar · NCT05170243
A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection
Last checked: Nov 20, 2026Latest source record: Dec 11, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Jan 21, 2022
Primary completion
Jul 3, 2022
Study completion Oct 28, 2022
Sponsor
- Lead sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 27, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a Phase 1, randomized, placebo-controlled study, enrolling approximately 38 healthy adult subjects (18-65 yrs). The purpose of this study is to evaluate the safety, tolerability and PK of single ascending dose of 9MW1911 administered intravenously (IV) in healthy adult volunteers. All subjects will be followed up for safety from the time of Informed Consent through 113 days post dose.
Conditions
- Asthma
- COPD
- Atopic Dermatitis
Interventions
9MW1911 InjectionDrug
Single dose intravenously on day 1
9MW1911 Injection PlaceboDrug
Single dose of matching placebo intravenously on day 1
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse Event(including serious adverse event)Time frame: up to day 113
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Shanghai Public Health Center
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.